Literature DB >> 21074133

Proteomic identification of serum peptides predicting subsequent spontaneous preterm birth.

M Sean Esplin1, Karen Merrell, Robert Goldenberg, Yinglei Lai, Jay D Iams, Brian Mercer, Catherine Y Spong, Menachem Miodovnik, Hygriv N Simhan, Peter van Dorsten, Mitchell Dombrowski.   

Abstract

OBJECTIVE: We sought to identify serum markers of subsequent spontaneous preterm birth (SPTB) in asymptomatic women prior to labor. STUDY
DESIGN: Serum proteomics was applied to sera from 80 pregnant women sampled at 24 weeks and an additional 80 pregnant women sampled at 28 weeks. Half had uncomplicated pregnancies and half had SPTB.
RESULTS: Three specific peptides arising from inter-alpha-trypsin inhibitor heavy chain 4 protein were significantly reduced in women at 24 and 28 weeks having subsequent SPTB. The most discriminating peptide had a sensitivity of 65.0% and specificity of 82.5%; odds ratio, 8.8; and 95% confidence interval, 3.1-24.8. A combination of the 3 new biomarkers and 6 previously studied biomarkers increased sensitivity to 86.5%, with a specificity of 80.6% at 28 weeks.
CONCLUSION: Three novel serum markers of SPTB have been identified using serum proteomics. Using a combination of these new markers with additional markers, women at risk of SPTB can be identified weeks prior to SPTB.
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21074133      PMCID: PMC3103758          DOI: 10.1016/j.ajog.2010.09.021

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  17 in total

1.  Analysis of low-abundance, low-molecular-weight serum proteins using mass spectrometry.

Authors:  Karen Merrell; Katie Southwick; Steven W Graves; M Sean Esplin; Nathan E Lewis; Craig D Thulin
Journal:  J Biomol Tech       Date:  2004-12

Review 2.  Prevention of premature birth.

Authors:  R L Goldenberg; D J Rouse
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

3.  Contribution of preterm delivery to perinatal mortality.

Authors:  R W Rush; M J Keirse; P Howat; J D Baum; A B Anderson; A C Turnbull
Journal:  Br Med J       Date:  1976-10-23

4.  Proteomic biomarker analysis of amniotic fluid for identification of intra-amniotic inflammation.

Authors:  Irina A Buhimschi; Rob Christner; Catalin S Buhimschi
Journal:  BJOG       Date:  2005-02       Impact factor: 6.531

5.  Proteomic analysis using protein chips to detect biomarkers in cervical and amniotic fluid in women with intra-amniotic inflammation.

Authors:  Ulla Rüetschi; Asa Rosén; Gösta Karlsson; Henrik Zetterberg; Lars Rymo; Henrik Hagberg; Bo Jacobsson
Journal:  J Proteome Res       Date:  2005 Nov-Dec       Impact factor: 4.466

6.  The Preterm Prediction Study: toward a multiple-marker test for spontaneous preterm birth.

Authors:  R L Goldenberg; J D Iams; B M Mercer; P J Meis; A Moawad; A Das; M Miodovnik; P J Vandorsten; S N Caritis; G Thurnau; M P Dombrowski
Journal:  Am J Obstet Gynecol       Date:  2001-09       Impact factor: 8.661

7.  Use of proteomic patterns in serum to identify ovarian cancer.

Authors:  Emanuel F Petricoin; Ali M Ardekani; Ben A Hitt; Peter J Levine; Vincent A Fusaro; Seth M Steinberg; Gordon B Mills; Charles Simone; David A Fishman; Elise C Kohn; Lance A Liotta
Journal:  Lancet       Date:  2002-02-16       Impact factor: 79.321

8.  Diagnosis of intra-amniotic infection by proteomic profiling and identification of novel biomarkers.

Authors:  Michael G Gravett; Miles J Novy; Ron G Rosenfeld; Ashok P Reddy; Thomas Jacob; Mark Turner; Ashley McCormack; Jodi A Lapidus; Jane Hitti; David A Eschenbach; Charles T Roberts; Srinivasa R Nagalla
Journal:  JAMA       Date:  2004-07-28       Impact factor: 56.272

9.  The length of the cervix and the risk of spontaneous premature delivery. National Institute of Child Health and Human Development Maternal Fetal Medicine Unit Network.

Authors:  J D Iams; R L Goldenberg; P J Meis; B M Mercer; A Moawad; A Das; E Thom; D McNellis; R L Copper; F Johnson; J M Roberts
Journal:  N Engl J Med       Date:  1996-02-29       Impact factor: 91.245

10.  ITIH4 (inter-alpha-trypsin inhibitor heavy chain 4) is a new acute-phase protein isolated from cattle during experimental infection.

Authors:  M Piñeiro; M Andrés; M Iturralde; S Carmona; J Hirvonen; S Pyörälä; P M H Heegaard; K Tjørnehøj; F Lampreave; A Piñeiro; M A Alava
Journal:  Infect Immun       Date:  2004-07       Impact factor: 3.441

View more
  40 in total

1.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

2.  A description of the methods of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b).

Authors:  David M Haas; Corette B Parker; Deborah A Wing; Samuel Parry; William A Grobman; Brian M Mercer; Hyagriv N Simhan; Matthew K Hoffman; Robert M Silver; Pathik Wadhwa; Jay D Iams; Matthew A Koch; Steve N Caritis; Ronald J Wapner; M Sean Esplin; Michal A Elovitz; Tatiana Foroud; Alan M Peaceman; George R Saade; Marian Willinger; Uma M Reddy
Journal:  Am J Obstet Gynecol       Date:  2015-01-31       Impact factor: 8.661

3.  Maternal serum serpin B7 is associated with early spontaneous preterm birth.

Authors:  Samuel Parry; Heping Zhang; Joseph Biggio; Radek Bukowski; Michael Varner; Yaji Xu; William W Andrews; George R Saade; M Sean Esplin; Rita Leite; John Ilekis; Uma M Reddy; Yoel Sadovsky; Ian A Blair
Journal:  Am J Obstet Gynecol       Date:  2014-06-19       Impact factor: 8.661

4.  Identification of Hip BMD Loss and Fracture Risk Markers Through Population-Based Serum Proteomics.

Authors:  Carrie M Nielson; Jack Wiedrick; Jian Shen; Jon Jacobs; Erin S Baker; Aaron Baraff; Paul Piehowski; Christine G Lee; Arie Baratt; Vladislav Petyuk; Shannon McWeeney; Jeong Youn Lim; Douglas C Bauer; Nancy E Lane; Peggy M Cawthon; Richard D Smith; Jodi Lapidus; Eric S Orwoll
Journal:  J Bone Miner Res       Date:  2017-04-06       Impact factor: 6.741

5.  Pre-pregnancy or first-trimester risk scoring to identify women at high risk of preterm birth.

Authors:  Rebecca J Baer; Monica R McLemore; Nancy Adler; Scott P Oltman; Brittany D Chambers; Miriam Kuppermann; Matthew S Pantell; Elizabeth E Rogers; Kelli K Ryckman; Marina Sirota; Larry Rand; Laura L Jelliffe-Pawlowski
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2018-11-05       Impact factor: 2.435

Review 6.  Advances in medical diagnosis of intra-amniotic infection.

Authors:  Irina A Buhimschi; Unzila A Nayeri; Christine A Laky; Sonya-Abdel Razeq; Antonette T Dulay; Catalin S Buhimschi
Journal:  Expert Opin Med Diagn       Date:  2012-08-17

Review 7.  Amniotic fluid: the use of high-dimensional biology to understand fetal well-being.

Authors:  Beena D Kamath-Rayne; Heather C Smith; Louis J Muglia; Ardythe L Morrow
Journal:  Reprod Sci       Date:  2013-04-18       Impact factor: 3.060

8.  3D Printed Microfluidic Devices for Microchip Electrophoresis of Preterm Birth Biomarkers.

Authors:  Michael J Beauchamp; Anna V Nielsen; Hua Gong; Gregory P Nordin; Adam T Woolley
Journal:  Anal Chem       Date:  2019-05-14       Impact factor: 6.986

Review 9.  The Use of Proteomics in Assisted Reproduction.

Authors:  Ioanna Kosteria; Athanasios K Anagnostopoulos; Christina Kanaka-Gantenbein; George P Chrousos; George T Tsangaris
Journal:  In Vivo       Date:  2017 May-Jun       Impact factor: 2.155

10.  Analysis of thrombin-antithrombin complex formation using microchip electrophoresis and mass spectrometry.

Authors:  Jacob B Nielsen; Anna V Nielsen; Richard H Carson; Hsien-Jung L Lin; Robert L Hanson; Mukul Sonker; Daniel N Mortensen; John C Price; Adam T Woolley
Journal:  Electrophoresis       Date:  2019-08-13       Impact factor: 3.535

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.